Biofrontera AG
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-4.85-4.94-6.72-5.65-11.76-0.69-0.470.16-0.07-5.47N/A-11.76
Price/Sales ratio
16.8013.3711.597.564.940.160.200.220.120.06N/A0.16
Price/Book Value ratio
-2.47K-11.514.4826.926.380.510.830.110.150.10N/A0.51
Price/Cash Flow ratio
-6.56-5.73-6.93-6.93-7.77-0.15-2.160.21-0.80-1.06N/A-7.77
Price/Free Cash Flow ratio
-6.42-5.62-6.61-6.73-7.48-0.14-1.700.21-0.64-0.71N/A-7.48
Price/Earnings Growth ratio
-1.142.420.26-0.330.22-0.00-0.01-0.000.000.05N/AN/A
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
63.92%70.13%73.05%85.73%78.91%86.09%88.34%86.40%81.51%80.64%N/A86.09%
Operating Profit Margin
-311.63%-247.24%-192.15%-115.87%-87.54%-69.77%-18.48%-55.17%6.18%14.82%N/A-87.54%
Pretax Profit Margin
-346.33%-270.73%-172.57%-133.90%-91.29%-15.27%-41.84%123.95%-167.88%-6.59%N/A-91.29%
Net Profit Margin
-346.33%-270.73%-172.57%-133.90%-42.06%-23.53%-42.91%133.10%-171.59%-1.14%N/A-42.06%
Effective Tax Rate
N/AN/AN/AN/A-53.92%-54.02%-2.56%5.11%-2.21%-82.65%N/A-53.92%
Return on Assets
-76.52%-117.95%-44.30%-81.12%-22.68%-12.60%-23.09%49.95%-134.96%-1.20%N/A-22.68%
Return On Equity
51054.70%232.95%-66.77%-476.24%-54.27%-73.91%-176.58%66.06%-217.18%-1.84%N/A-54.27%
Return on Capital Employed
-89.71%-159.33%-60.59%-88.54%-58.91%-46.62%-11.66%-26.81%6.53%23.14%N/A-58.91%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
2.971.844.123.583.141.592.580.541.221.25N/A1.59
Cash ratio
2.611.283.402.692.500.961.990.390.760.30N/A0.96
Days of Sales Outstanding
36.4378.9496.6947.3858.7458.7342.1015.2929.3581.00N/A58.73
Days of Inventory outstanding
455.48453.00805.56794.48260.52341.24482.36449.04367.83296.82N/A341.24
Operating Cycle
491.91531.94902.26841.86319.27399.97524.47464.33397.19377.83N/A399.97
Days of Payables Outstanding
316.21308.00462.43344.99148.09352.24167.53255.11152.23151.65N/A352.24
Cash Conversion Cycle
175.70223.94439.82496.87171.1747.73356.94209.21244.96226.17N/A47.73
Debt Ratios
Debt Ratio
0.761.260.160.630.340.330.350.02N/A0.00N/A0.33
Debt Equity Ratio
-513.08-2.500.243.700.831.932.730.03N/A0.00N/A1.93
Long-term Debt to Capitalization
1.001.740.180.780.450.650.73N/AN/AN/AN/A0.65
Total Debt to Capitalization
1.001.660.190.780.450.650.730.03N/A0.00N/A0.65
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.73-0.80-2.65-1.04-0.98-1.70-0.1414.55N/A-48.84N/A-0.98
Company Equity Multiplier
-667.19-1.971.505.872.395.867.641.321.601.53N/A5.86
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-2.56-2.33-1.67-1.09-0.63-1.05-0.091.05-0.15-0.05N/A-0.63
Free Cash Flow / Operating Cash Flow Ratio
1.021.011.041.031.031.051.270.971.251.47N/A1.05
Cash Flow Coverage Ratio
-0.73-0.80-2.65-1.04-0.98-1.70-0.1414.55N/A-48.84N/A-0.98
Short Term Coverage Ratio
N/A-11.63-37.44-77.17-81.41-189.04-34.7414.55N/A-48.84N/A-81.41
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A